!!!NEWSFLASH!!! Pre-emptive TAVI for asymptomatic severe aortic stenosis - From headlines to clinical practice
TAVI
Case-based Discussion
Innovation
Room 3
Anchorperson: Bernard Prendergast
Spokesperson: Philip Maccarthy
Discussants: Helene Eltchaninoff, Philippe Genereux, Rebecca Hahn, Thomas Treibel
Participants: Alexandra Baer, Rogério Eduardo Gomes Sarmento Leite, Sengottuvelu Gunasekaran, Kentaro Hayashida, Mahmoud Traina
Watch this session if you want
- To hear more about the recently published outcomes of the asymptomatic TAVI trials
- To understand how to synthesise and interpret this important clinical evidence
- To translate this understanding into your Heart Team's daily clinical practice
Welcome and session objectives
Bernard Prendergast
The early TAVR trial
Philippe Genereux
The EVOLVED trial
Thomas Treibel
Discussion and audience interaction
Philip Maccarthy
Synthesis - What DO these trials tell us (and what they DO NOT)?
Davide Capodanno
How will these trials influence Heart Team discussions?
Session evaluation and key learnings
Philip Maccarthy
